ZYBERNO
Stock Report
Updated Sep 1, 2026

VICARIOUS SURGICAL INC. (RBOT)

Healthcare • OTC

$0.04

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
10.0/100
POOR BUSINESS
VICARIOUS SURGICAL INC. (RBOT) scores 10/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-247.6%)
Debt-to-Equity (Solvency Risk):POOR (1.48x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-513.0%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

VICARIOUS SURGICAL INC. (RBOT) stock report — Zyberno Score 10/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.04
Market Cap:$260.55K

Valuation Multiples (2)

P/B Ratio:0.03x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:-$2.27M
B. Profitability Assessment

Return Metrics (5)

ROA:-138.6%
Reinvestment Rate:3.5%
Fundamental Growth Rate (g):-17.7%

Margin Analysis (1)

Ebitda Margin:0.0%

Yield Metrics (2)

Earnings Yield:-$4.75K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:2.97x
Quick Ratio:2.97x
Cash Ratio:2.51x

Leverage Analysis (3)

Debt To Equity Ttm:1.48x
Debt-to-Equity Ratio:1.48x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:7,680,000.00
Cash And Cash Equivalents:9,792,000.00
Long Term Debt:$5.84M
Net Debt:-$2.53M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$0.00
Cost Of Revenue Ttm:$0.00

Profitability Breakdown (2)

$0.00-$50.03M

Bottom Line Performance (3)

-$50.18M
Income Before Tax:-$50.18M
Ebitda Ttm:-48,602,000.00

Operating Expenses (5)

Operating Expenses:50,027,000.00
R And D Expense:33,601,000.00
Sga Expense:15,196,000.00
Income Tax Expense:$0.00
Interest Expense:0.00

Expense Ratios (1)

Ebitda Margin:0.0%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$19.58M
Current Assets:$11.58M
Ppe Net:7,076,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:9,740,000.00
Current Liabilities:3,904,000.00
Long Term Debt:$5.84M
Short Term Debt:$1.43M

Equity & Capital (3)

Equity:$9.84M
Retained Earnings:-$246.12M
Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:894,000.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:6,086,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$45.08M-$45.21M

Investment Activities (1)

Investing Cash Flow:$3.02M

Financing Activities (3)

Financing Cash Flow:$5.69M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:1,425,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-2.85
-$2.85
Earnings Per Share Ttm:-$8.19

Revenue & Cash Per Share (1)

Operating Cash Flow Per Share:-$7.35

Book Value & Capital (2)

Book Value Per Share:$1.61
Cash Per Share:1.60

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (1)

Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:-999.00
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:80.00
Quality Score:25.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:3.5%
Fundamental Growth Rate (g):-17.7%
B. Log-Linear Regression Growth Analysis

Other Growth Rates (1)

Book Value Growth Rate (Linear):-7.5%
C. Company Profile & Context

Corporate Information (6)

Symbol:RBOT
Company Name:VICARIOUS SURGICAL INC.
Sector:Healthcare
Industry:Medical Devices
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:6.13M
Shares Outstanding Basic:6.13M
Shares Outstanding Diluted:6.13M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-09-01 19:52:45 UTC
Data Timestamp:2026-08-22T08:23:56.625774
Scroll to Top